Doctor Explains GLP 1 Blindness Risk (Should You Be Worried?)
Dr. Jones, DC — Doctor Explains GLP 1 Blindness Risk (Should You Be Worried?)
Channel: Dr. Jones, DC · Our label: Chiropractor / clinician creator · Source: youtube.com/watch?v=saJqil8qpGs
What this video covers
If you’re taking a GLP1 medication or you’re thinking about starting one of these puppies, you probably have heard, how could you not, something about blindness. Oh, I’m not going to worry about blindness, blah blah blah blah. The sad reality of what you’re seeing out there is far from the real data. And so, that’s what I want to break down in this video is sift the truth from the BS.
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
- But my job though is to translate what your eye doctor and your prescribers aren’t explaining to each other or to you probably for that matter.
- Eye doctors call this the disc at risk anatomy.
- Your eye doctor can look at the back of your eye and tell you if you have a disc at risk setup.
- But that’s why I’m doing this video because while it is awful and I’m going to teach you guys how to minimize your risk, I think it’s important to take a step back and realize that the stats are the stats and that’s the real risk.
- The select trials looked at saglutide in adults with obesity and cardiovascular risk.
- So you’re not comparing drug risk to zero risk.
Read next
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.